Dietary Progesterone Contributes to Intratissue Levels of Progesterone in Male Mice.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
26 Jun 2023
Historique:
received: 26 04 2023
medline: 17 7 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

Progesterone serum levels have been identified as a potential predictor for treatment effect in men with advanced prostate cancer, which is an androgen-driven disease. Although progesterone is the most abundant sex steroid in orchiectomized (ORX) male mice, the origins of progesterone in males are unclear. To determine the origins of progesterone and androgens, we first determined the effect of ORX, adrenalectomy (ADX), or both (ORX + ADX) on progesterone levels in multiple male mouse tissues. As expected, intratissue androgen levels were mainly testicular derived. Interestingly, progesterone levels remained high after ORX and ORX + ADX with the highest levels in white adipose tissue and in the gastrointestinal tract. High progesterone levels were observed in mouse chow and exceptionally high progesterone levels were observed in food items such as dairy, eggs, and beef, all derived from female animals of reproductive age. To determine if orally ingested progesterone contributes to tissue levels of progesterone in males, we treated ORX + ADX and sham mice with isotope-labeled progesterone or vehicle by oral gavage. We observed a significant uptake of labeled progesterone in white adipose tissue and prostate, suggesting that dietary progesterone may contribute to tissue levels of progesterone. In conclusion, although adrenal-derived progesterone contributes to intratissue progesterone levels in males, nonadrenal progesterone sources also contribute. We propose that dietary progesterone is absorbed and contributes to intratissue progesterone levels in male mice. We speculate that food with high progesterone content could be a significant source of progesterone in males, possibly with consequences for men undergoing androgen deprivation therapy for prostate cancer.

Identifiants

pubmed: 37403231
pii: 7219205
doi: 10.1210/endocr/bqad103
pmc: PMC10345477
pii:
doi:

Substances chimiques

Androgens 0
Progesterone 4G7DS2Q64Y
Androgen Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swedish Research Council
ID : 2018-02600
Organisme : IngaBritt och Arne Lundbergs Forskningsstiftelse
ID : 2017-0081
Organisme : Novo Nordisk Foundation
ID : NNF19OC0055250
Organisme : Knut and Alice Wallenberg Foundation
ID : 2020.0230

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Clin Cancer Res. 2021 Nov 1;27(21):6001-6011
pubmed: 34407973
Clin Cancer Res. 2019 Jan 1;25(1):426-439
pubmed: 30181386
Prostate. 2019 Jun;79(9):937-948
pubmed: 31017696
Anim Reprod Sci. 2002 Oct 16;73(3-4):169-84
pubmed: 12363441
Am J Clin Nutr. 2019 Feb 1;109(2):402-410
pubmed: 30698629
Endocrinology. 2015 Jul;156(7):2492-502
pubmed: 25856427
Cell Rep Med. 2022 Mar 15;3(3):100561
pubmed: 35492874
J Pharm Pharmacol. 2012 Aug;64(8):1040-62
pubmed: 22775208
Cancer Res. 2006 Mar 1;66(5):2815-25
pubmed: 16510604
Sci Rep. 2016 Oct 17;6:35539
pubmed: 27748448
Nat Commun. 2022 May 13;13(1):2559
pubmed: 35562350
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1413-e1425
pubmed: 34865072
Int J Mol Sci. 2021 Jan 06;22(2):
pubmed: 33418978
Steroids. 2015 Nov;103:89-104
pubmed: 25846979
Endocr Rev. 2021 May 25;42(3):354-373
pubmed: 33480983
Sci Rep. 2018 Jul 27;8(1):11358
pubmed: 30054508
Am J Clin Nutr. 2015 Jan;101(1):87-117
pubmed: 25527754
J Steroid Biochem Mol Biol. 2012 Sep;131(3-5):107-21
pubmed: 22146616
Endocrinology. 2019 Oct 1;160(10):2395-2400
pubmed: 31199478
PLoS One. 2015 Feb 27;10(2):e0116691
pubmed: 25723513
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2021 Mar;38(3):409-417
pubmed: 33455529
J Steroid Biochem Mol Biol. 2015 Jun;150:35-45
pubmed: 25797030
Prostate. 2001 Sep 15;48(4):285-91
pubmed: 11536308
Int J Mol Sci. 2020 Feb 20;21(4):
pubmed: 32093338
Food Funct. 2022 Oct 17;13(20):10823-10833
pubmed: 36193812
J Steroid Biochem Mol Biol. 2017 Feb;166:91-96
pubmed: 27125450
Mol Cancer Res. 2022 Dec 2;20(12):1739-1750
pubmed: 36135372
J Natl Cancer Inst. 2005 Dec 7;97(23):1768-77
pubmed: 16333032
Am J Pathol. 2012 Sep;181(3):1078-87
pubmed: 22796438
Endocrinology. 2022 Oct 23;163(12):
pubmed: 36201601
Nutrients. 2019 Jul 16;11(7):
pubmed: 31315238
Aging Male. 2004 Sep;7(3):236-57
pubmed: 15669543
Endocrinology. 2023 Jun 26;164(8):
pubmed: 37403231
J Steroid Biochem Mol Biol. 2020 Feb;196:105499
pubmed: 31614208
Endocrinology. 2022 Mar 1;163(3):
pubmed: 34999782
Nutr Cancer. 2008;60(4):421-41
pubmed: 18584476
Asian Pac J Cancer Prev. 2020 Feb 01;21(2):423-429
pubmed: 32102520
J Investig Med. 2012 Feb;60(2):504-7
pubmed: 22064602
J Endocrinol. 2005 Nov;187(2):169-96
pubmed: 16293766
Life Sci. 1992;50(12):857-61
pubmed: 1312193
Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1182-E1192
pubmed: 31689143
Am J Pathol. 2018 Dec;188(12):2890-2901
pubmed: 30273606

Auteurs

Hannah Colldén (H)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Malin Hagberg Thulin (M)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Andreas Landin (A)

Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg SE-413 45, Sweden.

Karin Horkeby (K)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Marie Lagerquist (M)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Jianyao Wu (J)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Karin H Nilsson (KH)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Louise Grahnemo (L)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Matti Poutanen (M)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine and Turku Center for Disease Modeling, University of Turku, Turku FI-20014, Finland.

Henrik Ryberg (H)

Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg SE-413 45, Sweden.

Liesbeth Vandenput (L)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC 3000, Australia.

Claes Ohlsson (C)

Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH